LILRA2 tissues
LILRA2 [ENSP00000375618]
Leukocyte immunoglobulin-like receptor subfamily A member 2; Part of the innate immune responses against microbial infection . Specifically recognizes a set of N-terminally truncated immunoglobulins that are produced via cleavage by proteases from a range of pathogenic bacteria and fungi, including L.pneumophila, M.hyorhinis, S.pneumoniae, S.aureus and C.albicans . Recognizes epitopes that are in part in the variable region of the immunoglobulin light chains, but requires also the constant region for signaling . Binds to a subset of cleaved IgM, IgG3 and IgG4 molecules, but does not bind cleaved IgA1 . Binding of N-terminally truncated immunoglobulins mediates activation of neutrophils . In monocytes, activation leads to the release of CSF2, CF3, IL6, CXCL8 and CCL3 and down-regulates responses to bacterial lipopolysaccharide (LPS), possibly via down-regulation of TLR4 expression and reduced signaling via TLR4 . In eosinophils, activation by ligand binding leads to the release of RNASE2, IL4 and leukotriene C4 . Does not bind class I MHC antigens . ECO:0000269|PubMed:19230061, ECO:0000269|PubMed:22479404,
Synonyms: LILRA2, LILRA2p, hLILRA2, A0A087WT41, A0A0D9SFC7 ...